Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04793919 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 15, 2024 (before its estimated October 9, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 10, 2022 to Oct 9, 2025
    • Study completion date: Oct 10, 2024 to Oct 10, 2027
    v4
  2. Study sites revised (31)v3
  3. Site details revised at 9 of 31 sitesv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The trial is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who are PCR-positive for the PML-RARα transcript and less than 18 years of age.
Trial Details
NCT Number NCT04793919
Lead Sponsor Associazione Italiana Ematologia Oncologia Pediatrica
Conditions
(from sponsor)		 Acute Promyelocytic Leukemia
Related terms Leukemia, Promyelocytic, Acute
Enrollment 89 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov